Refine
Year of publication
- 2014 (4) (remove)
Language
- English (4) (remove)
Keywords
- AhRR (1)
- CYP1A1 (1)
- DL-PCBs (1)
- Dioxin (1)
- EROD (1)
- Ileostomy (1)
- Immunoblot (1)
- Microarray (1)
- PCDD/Fs (1)
- TIPARP (1)
Faculty / Organisational entity
- Fachbereich Chemie (4) (remove)
ABSTRACT
"Spin and orbital contribution to the magnetic moment of transition metal clusters and complexes"
The spin and orbital contributions to the magnetic moments of isolated iron \(Fe_n^+\) \((7 ≤ n ≤ 18)\), cobalt \(Co_n^+\) \((8 ≤ n ≤ 22)\) and nickel \(Ni_n^+\) \((7 ≤ n ≤ 17)\) clusters were investigated. An experimental access to both contributions is possible by the application of x-ray magnetic circular dichroism (XMCD) spectroscopy. XMCD spectroscopy is based on x-ray absorption spectroscopy (XAS). It exploits the fact that for a magnetic sample the resonant absorption cross sections for negative and positive circular polarized x-rays differ for the transition from a spin orbit split ground state to the valence level. The resulting dichroic effects contain the information about the magnetism of the investigated sample. It can be extracted from the experimental spectrum via application of the so called sum rules. However, only the projections of the magnetic moments onto the quantization axis are experimentally accessible which corresponds to the magnetization of the sample.
We developed a method to apply XMCD spectroscopy to isolated clusters in the gas phase. A modified Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass spectrometer was used to record the XA spectra in Total Ion Yield (TIY) mode, i.e. by recording the fragmentation intensity of the clusters in dependence of x-ray energy. The clusters can be considered to be a superparamagnetic ensemble. Thus, the magnetization follows a Langevin curve. The intrinsic magnetic moments can be calculated by Langevin correction of the experimental magnetic moments because the cluster temperature and the magnetic field are known.
The spin and the orbital magnetic moments are enhanced compared to the respective bulk values for all three investigated elements. The enhancement of the orbital contribution is more pronounced, by about a factor 3 - 4 compared to the bulk, than for the spin magnetic moment. However, if compared to the atomic value, both contributions are quenched. The orbital magnetic moment only amounts to about 10 - 15 % of the atomic value while the spin retains about 80 % of its atomic value. If the magnetic moments found for the clusters are put into perspective with respect to the atomic and bulk values by means of scaling laws, it becomes evident that both contributions follow different interpolations between the atomic and bulk value. The spin follows the well-known trend
\(n^{-1/3} = 1/(cluster radius)\) (n = number of atoms per cluster, assumption of a spherical particle). This trend relates to the ratio of surface to inner atoms in spherical particle. Hence, our interpretation is that the spin magnetic moment seems to follow the surface area of the cluster. On the other hand, the orbital magnetic moment follows \(1/n = 1/(cluster volume)\).
First XA spectra recorded with circularly polarized x-rays of a Single Molecule Magnet (SMM) \([Fe_4Ln_2(N_3)_4(Htea)_4(piv_6)]\) (Ln = Gd, Tb; \(H_3tea\) = triethanolamine, Hpiv = pivalic acid) are presented.
This thesis combines mass spectrometric studies on ionic dicarboxylic acids and transition metal cluster adsorbate complexes. IR-MPD spectra of protonated and deprotonated aliphatic and aromatic dicarboxylic acids provide insights in the nature of intramolecular hydrogen bonding. Investigations of their fragmentation behavior are supported by MP2 calculations. Prior work on cobalt transition metal clusters is extended to iron and nickel and three cobalt alloys have been studied.
‘Dioxin-like’ (DL) compounds occur ubiquitously in the environment. Toxic responses associated with specific dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and polychlorinated biphenyls (PCBs) include dermal toxicity, immunotoxicity, liver toxicity, carcinogenicity, as well as adverse effects on reproduction, development, and endocrine functions. Most, if not all of these effects are believed to be due to interaction of these compounds with the aryl hydrocarbon receptor (AhR).
With tetrachlorodibenzo-p-dioxin (TCDD) as representatively most potent congener, a toxic equivalency factor (TEF) concept was employed, in which respective congeners were assigned to a certain TEF-value reflecting the compound’s toxicity relative to TCDD’s.
The EU-project ‘SYSTEQ’ aimed to develop, validate, and implement human systemic TEFs as indicators of toxicity for DL-congeners. Hence, the identification of novel quantifiable biomarkers of exposure was a major objective of the SYSTEQ project.
In order to approach to this objective, a mouse whole genome microarray analysis was applied using a set of seven individual congeners, termed the ‘core congeners’. These core congeners (TCDD, 1-PeCDD, 4-PeCDF, PCB 126, PCB 118, PCB 156, and the non dioxin-like PCB 153), which contribute to approximately 90% of toxic equivalents (TEQs) in the human food chain, were further tested in vivo as well as in vitro. The mouse whole genome microarray revealed a conserved list of differentially regulated genes and pathways associated with ‘dioxin-like’ effects.
A definite data-set of in vitro studies was supposed to function as a fundament for a probable establishment of novel TEFs. Thus, CYP1A induction measured by EROD activity, which represents a sensitive and yet best known marker for dioxin-like effects, was used to estimate potency and efficacy of selected congeners. For this study, primary rat hepatocytes and the rat hepatoma cell line H4IIE were used as well as the core congeners and an additional group of compounds of comparable relevance for the environment: 1,6-HxCDD, 1,4,6-HpCDD, TCDF, 1,4-HxCDF, 1,4,6-HpCDF, PCB 77, and PCB 105.
Besides, a human whole genome microarray experiment was applied in order to gain knowledge with respect to TCDD’s impact towards cells of the immune system. Hence, human primary blood mononuclear cells (PBMCs) were isolated from individuals and exposed to TCDD or to TCDD in combination with a stimulus (lipopolysaccharide (LPS), or phytohemagglutinin (PHA)). A few members of the AhR-gene batterie were found to be regulated, and minor data with respect to potential TCDD-mediated immunomodulatory effects were given. Still, obtained data in this regard was limited due to great inter-individual differences.
A positive affection of human health by nutrition is of high interest, especially for bioactive compounds which are consumed daily in high amounts. This is the case for chlorogenic acids (CGA) ingested by coffee. This molecule class is associated with several possible beneficial health effects observed in vitro that strongly depend on their bioavailability. So far factors influencing bioavailability of CGA such as dose, molecule structure and site of absorption haven´t been investigated sufficiently.
Therefore we performed an in vivo dose-response study with ileostomists, who consumed three different nutritional doses of CGA ingested as instant coffee (4,525 (HIGH); 2,219 (MEDIUM); 1,053 (LOW) μmol CGA). CGA concentrations were determined in ileal fluid, urine and plasma. Furthermore, we conducted an ex vivo study with pig jejunal mucosa using the Ussing chamber model to confirm the in vivo observations. Individual transfer rates of CGA from coffee were investigated, namely: caffeoylquinic acid (CQA), feruloylquinic acid (FQA), caffeic acid (CA), dicaffeoylquinic acid (diCQA) and QA at physiological concentrations (0.2–3.5 mM). Samples were analyzed by HPLC-DAD, -ESI-MS and -ESI-MS/MS.
About ⅔ of the ingested CGA by coffee consumption were available in the colon dose independent. Nevertheless, the results showed that the consumption of higher CGA doses leads to a faster ileal excretion. This corresponds to a plasma AUC0-8h for CGA and metabolites of 4,412 ± 751 nM*h0-8-1 (HIGH), 2,394 ± 637 nM*h0-8-1 (MEDIUM) and 1,782 ± 731 nM*h0-8-1 (LOW) respectively, and a renal excretion of 8.0 ± 4.9% (HIGH), 12.1 ± 6.7% (MEDIUM) and 14.6 ± 6.8% (LOW). Moreover interindividual differences in gastrointestinal transit times were related to differences in total CGA absorption. Thus the variety of patient´s physiology is a decisive bioavailability factor for CGA uptake. This is corroborated ex vivo by a direct proportional relationship of incubation time with absorbed CGA amount.
The consumption of high CGA doses influences the metabolism pattern as an increasing glucuronidation was observed with consumption of increasing CGA doses. However, the different CGA doses have only minor effects on the overall bioavailability which was confirmed ex vivo by a non-saturable passive diffusion of 5-CQA. Furthermore, we identified in the Ussing chamber an active efflux secretion for 5-CQA that decreases its bioavailability and the physicochemical properties of the CGA subgroups as an important bioavailability factor. Transferred amount in increasing order: diCQA, trace amounts; CQA ≈ 1%; CA ≈ 1.5%; FQA ≈ 2%; and QA ≈ 4%.
Altogether, the consumption of increasing CGA doses by coffee had a minor effect on oral bioavailability in ileostomists, such as a slightly increased glucuronidation. Thus, the consumption of high amounts of CGA from coffee in the daily diet is not limiting the CGA concentrations at the site of possible health effects in the human body. However, according to the patient´s physiology the interindividual gastrointestinal transit time which is possibly influenced by dose is influencing CGA bioavailability. Moreover, ex vivo CGA absorption is governed by diffusion as an absorption mechanism corroborating an unsaturable uptake in vivo and by the individual physicochemical properties of CGA.
